XENE - Xenon Pharmaceuticals Stock Price

Graphic logo of Xenon Corp (XENE)

Xenon Pharmaceuticals (XENE) is implementing AI and robotics to accelerate drug discovery, minimizing manual labor in laboratories. However, revenue shortfalls and R&D expenses are creating a cash gap, resulting in a figure of 39.38. This chart of the company's market valuation clearly demonstrates current asset dynamics. The business relies on Canadian developments in targeted epilepsy therapy and collaboration with leading scientific institutes.

Share Price: Xenon Corp (XENE) for 07/04/2022 - 11/17/2026

Xenon Pharmaceuticals Inc (XENE) - metric breakdowns and financial figures

Analysis of all company metrics:xenon-pharma.com XENE
Signature product of Xenon Pharmaceuticals Inc.

A defensive portfolio is constructed by selecting assets with high fundamental stability. The current share price reflects the market consensus on business value and serves as the basis for calculating growth potential relative to target forecasts. For Xenon Pharmaceuticals (XENE), this metric accounts for future cash flows from epilepsy therapy. Long-term demand for such drugs stabilizes investment attractiveness, and real-time quotes reflect the dynamics of these expectations.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|Viking Therapeutics, Inc. - Price|Supernus Pharma (SUPN) - Price Chart|Share Price CPRX|Price Chart Denali Therapeutics|Share Price HRMY (Harmony Pharma)|Stock Price BHVN|AMLX - Market Price|trevitherapeutics.com - Stock Quotes|Stock Price Praxis Precision Medicines Inc PRAX|AVXL - Price Chart|Price Performance Chart CBLL (CeriBell EEG)|Prothena Corporation (PRTA) - Price Chart|Market Price Alector Inc. (ALEC)|ANNX (annexonbio.com) - Stock Price|Market Price omeros.com OMER|Stock Price NGNE|Stock Quotes AC Immune ACIU|Voyager Therapeutics Inc - Stock Quotes|Stock Price neumoratx.com NMRA|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel